Chronic Ischemic cardiopathy

Arterial Accesses

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality...

Dr. Omar Tupayachi - 21 April, 2025

Acute coronary syndromes

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The...

Dr. Omar Tupayachi - 11 April, 2025

Antiplatelet

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a...

Dr. Andrés Rodríguez - 8 April, 2025

Chronic Coronary Syndromes

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive...

Dr. Omar Tupayachi - 8 April, 2025

Chronic Coronary Syndromes

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the...

Dr. Omar Tupayachi - 8 April, 2025

Chronic Coronary Syndromes

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events...

Dr. Omar Tupayachi - 2 April, 2025

Chronic Coronary Syndromes

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and...

Dr. Omar Tupayachi - 25 March, 2025

Chronic Coronary Syndromes

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization....

Dr. Andrés Rodríguez - 19 March, 2025

Chronic Ischemic cardiopathy

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

Últimas Noticias

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Noticias Institucionales

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

Watch our event on Evidence and Controversies of Renal Denervation in 2025

Accesos